HK1222905A1 - 與腎功能相關的生物標記及其使用方法 - Google Patents
與腎功能相關的生物標記及其使用方法Info
- Publication number
- HK1222905A1 HK1222905A1 HK16110994.7A HK16110994A HK1222905A1 HK 1222905 A1 HK1222905 A1 HK 1222905A1 HK 16110994 A HK16110994 A HK 16110994A HK 1222905 A1 HK1222905 A1 HK 1222905A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- same
- kidney function
- biomarkers related
- biomarkers
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/64—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving ketones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361822965P | 2013-05-14 | 2013-05-14 | |
PCT/US2014/037762 WO2014186311A1 (en) | 2013-05-14 | 2014-05-13 | Biomarkers related to kidney function and methods using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1222905A1 true HK1222905A1 (zh) | 2017-07-14 |
Family
ID=51898805
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16106343.3A HK1218331A1 (zh) | 2013-05-14 | 2016-06-03 | 與腎功能相關的生物標記及其使用方法 |
HK16110994.7A HK1222905A1 (zh) | 2013-05-14 | 2016-09-19 | 與腎功能相關的生物標記及其使用方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16106343.3A HK1218331A1 (zh) | 2013-05-14 | 2016-06-03 | 與腎功能相關的生物標記及其使用方法 |
Country Status (11)
Country | Link |
---|---|
US (2) | US10539575B2 (zh) |
EP (3) | EP3410115A1 (zh) |
JP (1) | JP6595984B2 (zh) |
CN (2) | CN105209909B (zh) |
AU (1) | AU2014265669B2 (zh) |
BR (1) | BR112015028253A2 (zh) |
CA (2) | CA3184836A1 (zh) |
ES (2) | ES2871823T3 (zh) |
HK (2) | HK1218331A1 (zh) |
MX (2) | MX365061B (zh) |
WO (1) | WO2014186311A1 (zh) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2871823T3 (es) * | 2013-05-14 | 2021-11-02 | Metabolon Inc | Biomarcadores relacionados con la función renal y métodos para utilizarlos |
KR20170102983A (ko) * | 2015-01-09 | 2017-09-12 | 글로벌 게노믹스 그룹, 엘엘씨 | 죽상 경화성 관상 동맥 질환을 진단하기 위한 혈액 기반 바이오마커 |
US20180003721A1 (en) * | 2015-01-15 | 2018-01-04 | Joslin Diabetes Center | Metabolite Biomarkers Predictive Of Renal Disease In Diabetic Patients |
EP3355914B1 (en) * | 2015-09-29 | 2024-03-06 | The General Hospital Corporation | A composition comprising bcg for reducing cholesterol. |
US20170234874A1 (en) * | 2015-10-07 | 2017-08-17 | Clearbridge Biophotonics Pte Ltd. | Integrated visual morphology and cell protein expression using resonance-light scattering |
CN109563127B (zh) * | 2016-07-28 | 2024-01-05 | 麦特博隆股份有限公司 | 化合物、试剂及其用途 |
JP7097380B2 (ja) * | 2016-11-25 | 2022-07-07 | ベケッド、フレデリク | 代謝性障害 |
AU2017382744B2 (en) * | 2016-12-19 | 2023-02-09 | Metabolon, Inc. | Mass spectrometry assay method for detection and quantitation of kidney function metabolites |
CN108956790A (zh) * | 2017-05-18 | 2018-12-07 | 中国人民解放军第二军医大学第二附属医院 | 一组氨基酸标志物在急性肾损伤诊断试剂盒中的应用 |
CN107132266A (zh) * | 2017-06-21 | 2017-09-05 | 佛山科学技术学院 | 一种基于随机森林的水质分类方法及系统 |
AU2018313853A1 (en) | 2017-08-08 | 2020-01-02 | Fresenius Medical Care Holdings, Inc. | Systems and methods for treating and estimating progression of chronic kidney disease |
CN107326093B (zh) * | 2017-09-04 | 2020-01-21 | 东南大学 | 基于Taqman探针的慢性肾脏病相关基因检测荧光定量PCR一步法试剂盒及其应用 |
EP3688470A1 (en) * | 2017-09-28 | 2020-08-05 | Metabolon, Inc. | Compounds, reagents, and uses thereof |
CN111936859A (zh) * | 2018-01-19 | 2020-11-13 | 马斯公司 | 用于猫中慢性肾脏病的生物标志物和分类算法 |
US20210327589A1 (en) * | 2018-07-14 | 2021-10-21 | Mars, Incorporated | Biomarkers and test models for chronic kidney disease |
WO2020171158A1 (ja) * | 2019-02-20 | 2020-08-27 | 株式会社パートナーファーム | 固相反応チップ及びこれを用いた測定方法 |
CN112305089B (zh) * | 2019-07-26 | 2022-04-29 | 长沙都正生物科技股份有限公司 | 一种慢性肾病诊断生物标记物及其应用 |
MX2022001087A (es) * | 2019-07-26 | 2022-04-07 | Fundacio Inst Dinvestigacio Biomedica De Bellvitge Idibell | Ergotioneina, s-metil-ergotioneina, y usos de las mismas. |
CN111487338B (zh) * | 2020-04-16 | 2022-06-10 | 中南大学湘雅二医院 | 一种与肾功能相关的无创生物标记物及其应用 |
CN114026427B (zh) * | 2020-05-19 | 2023-11-17 | 深圳市中医院 | 诊断肾病的标志物以及诊断方法 |
CN114910587B (zh) * | 2022-05-12 | 2024-03-19 | 军科正源(上海)生物医药科技有限公司 | 一种尿液检测用高效液相-串联质谱分析方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02196787A (ja) | 1989-01-25 | 1990-08-03 | Otsuka Pharmaceut Co Ltd | シュードウリジン誘導体 |
JPH0661278B2 (ja) | 1990-09-18 | 1994-08-17 | 旭化成工業株式会社 | ミオイノシトールの高感度定量法および定量用組成物 |
US5712084A (en) * | 1995-09-08 | 1998-01-27 | Research Corporation Technologies, Inc. | Donor kidney viability test for improved preservation |
CN101377492B (zh) * | 2007-08-29 | 2014-04-23 | 北京九强生物技术股份有限公司 | 胱抑素c测定试剂盒 |
CA2735590A1 (en) * | 2008-08-29 | 2010-03-04 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US9421330B2 (en) | 2008-11-03 | 2016-08-23 | Bayer Healthcare Llc | Mitigation of contrast-induced nephropathy |
CA2743253A1 (en) * | 2008-11-22 | 2010-05-27 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
WO2010124269A1 (en) * | 2009-04-24 | 2010-10-28 | National Center For Genome Resources | Methods for diagnosis of sepsis and risk of death |
JP5197846B2 (ja) | 2009-04-30 | 2013-05-15 | 紀陽 田仲 | 腎疾患重篤度を判定する方法又は装置若しくはその作動方法 |
EP3276004B1 (en) | 2009-06-08 | 2020-03-18 | Quark Pharmaceuticals, Inc. | Methods for treating chronic kidney disease |
US8709816B2 (en) | 2009-09-04 | 2014-04-29 | Tohoku University | Human renal disease marker substance |
KR20120123056A (ko) | 2009-12-20 | 2012-11-07 | 아스튜트 메디컬 인코포레이티드 | 신손상 및 신부전을 진단 및 예측하는 방법 및 조성물 |
WO2011146683A1 (en) * | 2010-05-19 | 2011-11-24 | Metabolon, Inc. | Methods and reagents for metabolomics and histology in a biological sample and a kit for the same |
US9465039B2 (en) | 2010-08-06 | 2016-10-11 | Mycartis Nv | Perlecan as a biomarker for renal dysfunction |
JP5916058B2 (ja) | 2011-08-26 | 2016-05-11 | 国立大学法人東北大学 | 細胞ストレス状態のバイオマーカー |
JP2014530350A (ja) | 2011-09-14 | 2014-11-17 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | 腎臓毒性を評価するための手段及び方法 |
WO2013048344A1 (en) * | 2011-09-29 | 2013-04-04 | National University Of Singapore | Urinary metabolomic markers for renal insufficiency |
ES2871823T3 (es) * | 2013-05-14 | 2021-11-02 | Metabolon Inc | Biomarcadores relacionados con la función renal y métodos para utilizarlos |
CN109563127B (zh) * | 2016-07-28 | 2024-01-05 | 麦特博隆股份有限公司 | 化合物、试剂及其用途 |
-
2014
- 2014-05-13 ES ES19176215T patent/ES2871823T3/es active Active
- 2014-05-13 MX MX2015015561A patent/MX365061B/es active IP Right Grant
- 2014-05-13 EP EP18183240.3A patent/EP3410115A1/en not_active Withdrawn
- 2014-05-13 US US14/889,930 patent/US10539575B2/en active Active
- 2014-05-13 JP JP2016514016A patent/JP6595984B2/ja active Active
- 2014-05-13 ES ES14797070T patent/ES2702123T3/es active Active
- 2014-05-13 CA CA3184836A patent/CA3184836A1/en active Pending
- 2014-05-13 CN CN201480027332.7A patent/CN105209909B/zh active Active
- 2014-05-13 BR BR112015028253A patent/BR112015028253A2/pt not_active Application Discontinuation
- 2014-05-13 CN CN201910484069.9A patent/CN110196335A/zh active Pending
- 2014-05-13 WO PCT/US2014/037762 patent/WO2014186311A1/en active Application Filing
- 2014-05-13 CA CA2911204A patent/CA2911204C/en active Active
- 2014-05-13 AU AU2014265669A patent/AU2014265669B2/en active Active
- 2014-05-13 EP EP19176215.2A patent/EP3546940B1/en active Active
- 2014-05-13 EP EP14797070.1A patent/EP2997366B1/en active Active
-
2015
- 2015-11-10 MX MX2019005748A patent/MX2019005748A/es unknown
-
2016
- 2016-06-03 HK HK16106343.3A patent/HK1218331A1/zh unknown
- 2016-09-19 HK HK16110994.7A patent/HK1222905A1/zh unknown
-
2019
- 2019-12-02 US US16/700,098 patent/US20200103417A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP6595984B2 (ja) | 2019-10-23 |
BR112015028253A2 (pt) | 2017-07-25 |
ES2871823T3 (es) | 2021-11-02 |
CN105209909A (zh) | 2015-12-30 |
AU2014265669B2 (en) | 2020-05-14 |
CN105209909B (zh) | 2019-06-07 |
US20200103417A1 (en) | 2020-04-02 |
CA2911204C (en) | 2023-03-28 |
CN110196335A (zh) | 2019-09-03 |
EP2997366A1 (en) | 2016-03-23 |
ES2702123T3 (es) | 2019-02-27 |
CA2911204A1 (en) | 2014-11-20 |
MX2015015561A (es) | 2016-02-05 |
US20160116486A1 (en) | 2016-04-28 |
EP2997366A4 (en) | 2017-04-12 |
EP3546940A1 (en) | 2019-10-02 |
EP3546940B1 (en) | 2021-02-17 |
US10539575B2 (en) | 2020-01-21 |
CA3184836A1 (en) | 2014-11-20 |
JP2016520192A (ja) | 2016-07-11 |
EP3410115A1 (en) | 2018-12-05 |
AU2014265669A1 (en) | 2015-12-24 |
WO2014186311A1 (en) | 2014-11-20 |
HK1218331A1 (zh) | 2017-02-10 |
MX365061B (es) | 2019-05-22 |
EP2997366B1 (en) | 2018-10-10 |
MX2019005748A (es) | 2019-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1222905A1 (zh) | 與腎功能相關的生物標記及其使用方法 | |
IL261743B (en) | and their uses 33–il antibodies against | |
HK1214969A1 (zh) | 抗- -β抗體及其使用 | |
IL261547B (en) | Antibodies against pesidine and their uses | |
IL243974A0 (en) | Antibodies against -prlr and uses | |
ZA201508896B (en) | Anti-c10orf54 antibodies and uses thereof | |
HK1217516A1 (zh) | 與胰島素抗性進程相關的生物標誌物和其用途 | |
EP2989214A4 (en) | IN SITU INTERACTION DETERMINATION | |
SG11201509116VA (en) | Anti-tweakr antibodies and uses thereof | |
GB201312318D0 (en) | Novel methods and compounds | |
ZA201601606B (en) | Methods and compositions for improving kidney function | |
GB201307989D0 (en) | Novel combinations and use | |
SG11201600737TA (en) | Instrument changing assembly and methods | |
GB2515495B (en) | Permeability determination | |
GB201320992D0 (en) | Complex and uses thereof | |
EP2965661A4 (en) | CARTABLE CHAIR TRANSPORTABLE | |
GB201311696D0 (en) | Assembly and methods | |
HK1193539A2 (zh) | 便携式物品 | |
GB201309248D0 (en) | Compounds and combinations | |
GB201306469D0 (en) | Above the law |